» Articles » PMID: 39823439

Hepatic and Pancreatic Cellular Response to Early Life Nutritional Mismatch

Overview
Journal Endocrinology
Date 2025 Jan 17
PMID 39823439
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the basis for perinatal nutritional mismatch causing metabolic dysfunction-associated steatotic liver disease and diabetes mellitus, we examined adult phenotype, hepatic transcriptome, and pancreatic β-islet function. In prenatal caloric-restricted rats with intrauterine growth restriction (IUGR) and postnatal exposure to high fat with fructose (HFhf) or high carbohydrate, we investigated male and female IUGR-HFhf and IUGR-high carbohydrate, vs HFhf and control offspring. Males more than females displayed adiposity, glucose intolerance, insulin resistance, hyperlipidemia, and hepatomegaly with hepatic steatosis. Male hepatic triglyceride synthesis, de novo lipogenesis genes increased, while female lipolysis, β-oxidation, fatty acid efflux, and FGF21 genes increased. IUGR-HFhf males demonstrated reduced β-islet insulin and humanin, and type 1 diabetes mellitus human amniotic fluid increased humanin. Humanin suppression disabled glucose stimulated insulin, ATP production, with apoptotic diminished β-islet viability. Humanin and FGF21 may reverse perinatal nutritional mismatched phenotype by restoring functional β islets and preventing metabolic dysfunction-associated steatotic liver disease and diabetes mellitus.

Citing Articles

Hepatic and Pancreatic Cellular Response to Early Life Nutritional Mismatch.

Ghosh S, Ganguly A, Habib M, Shin B, Thamotharan S, Andersson S Endocrinology. 2025; 166(3).

PMID: 39823439 PMC: 11815087. DOI: 10.1210/endocr/bqaf007.

References
1.
Hoang P, Park P, Cobb L, Paharkova-Vatchkova V, Hakimi M, Cohen P . The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism. 2009; 59(3):343-9. PMC: 2932671. DOI: 10.1016/j.metabol.2009.08.001. View

2.
Matveyenko A, Singh I, Shin B, Georgia S, Devaskar S . Differential effects of prenatal and postnatal nutritional environment on ß-cell mass development and turnover in male and female rats. Endocrinology. 2010; 151(12):5647-56. PMC: 2999501. DOI: 10.1210/en.2010-0978. View

3.
Escobar J, Teramo K, Stefanovic V, Andersson S, Asensi M, Arduini A . Amniotic fluid oxidative and nitrosative stress biomarkers correlate with fetal chronic hypoxia in diabetic pregnancies. Neonatology. 2013; 103(3):193-8. DOI: 10.1159/000345194. View

4.
Gaich G, Chien J, Fu H, Glass L, Deeg M, Holland W . The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013; 18(3):333-40. DOI: 10.1016/j.cmet.2013.08.005. View

5.
Alisi A, Panera N, Agostoni C, Nobili V . Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. Int J Endocrinol. 2011; 2011:269853. PMC: 3235463. DOI: 10.1155/2011/269853. View